| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/10/2004 | CN1481361A Piperidine MCH antagonists and their use in treatment of obesity |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1481247A Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 03/10/2004 | CN1481240A Antilipemic agents |
| 03/10/2004 | CN1481239A Compsns for improving lipids in blood |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1481236A Aerogel powder comprising therapeutic agents |
| 03/10/2004 | CN1480528A Bifidobacterium and products contg same |
| 03/10/2004 | CN1480462A Etractive of fenugreek and its producing method |
| 03/10/2004 | CN1480461A Metching substance with flavone contained in erigeron breviscapus as ligand and its usage |
| 03/10/2004 | CN1480454A Antagon of endostadin receptor pyrazole carboxylic acids |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480202A Propolis drop pills and its preparing method |
| 03/10/2004 | CN1480200A Penetrating fluid for acupuncture point of electrotherapeutics |
| 03/10/2004 | CN1480164A Medication for treating diabetic retinopathy and its preparing method |
| 03/10/2004 | CN1480158A Fish brain oil and method for extracting it |
| 03/10/2004 | CN1480157A Preparation capable of promoting growth and intelligence development for teenagers and children as well as its preparing method |
| 03/10/2004 | CN1480146A Preparation capable of regulating blood fat, blood pressure and blood sugar for protecting heart and brain cells as well as its prearing method |
| 03/10/2004 | CN1480135A Different medicament forms of druggery or health products produced from laevorotation-theanine as active component |
| 03/10/2004 | CN1480134A Combination of iodine amino acid as well as its preparation method and application |
| 03/10/2004 | CN1141125C Traditional Chinese medicine compsn with hypolycemic function |
| 03/10/2004 | CN1141118C Prepn method for hualu health nutritive article |
| 03/10/2004 | CN1141104C Soft yoke oil capsule |
| 03/10/2004 | CN1141086C Hypoglycemic Chinese medicine 'yanzizhang' and its preparing process |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/09/2004 | US6703410 Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment |
| 03/09/2004 | US6703389 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 03/09/2004 | US6703386 Treating hyperlipidemia, arteriosclerosis and hypercholesterolemia; derivatives of ezetimibe that are absorbed to a very low extent and so have a side effect reduction |
| 03/09/2004 | US6703371 Preparations for reducing oxygen consumption during physical efforts |
| 03/09/2004 | US6703369 Lipase inhibiting compositions |
| 03/09/2004 | US6703365 Glucagon-like insulinotropic peptides, compositions and methods |
| 03/09/2004 | US6703361 Method of treating or preventing Type 1 diabetes by oral administration of insulin |
| 03/09/2004 | US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity |
| 03/09/2004 | US6703214 Microscopic nematodes in functional high throughput in vivo assays for detection of inhibitors or activators of intestinal lipid uptake |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018669A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | WO2004018598A1 Fat composition |
| 03/04/2004 | WO2004018491A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 03/04/2004 | WO2004018483A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 03/04/2004 | WO2004018473A2 Azapurine derivatives |
| 03/04/2004 | WO2004018469A1 Novel purine derivatives, production and use thereof as medicaments |
| 03/04/2004 | WO2004018468A2 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 03/04/2004 | WO2004018467A2 Phenacyl xanthine derivatives as dpp-iv inhibitor |
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 03/04/2004 | WO2004018455A1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018432A1 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 03/04/2004 | WO2004018429A2 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004018411A1 Muscarinic agonists |
| 03/04/2004 | WO2004018041A1 Use of a ppar-alpha agonist to treat weight gain associated with a ppar-gamma agonist treatment |
| 03/04/2004 | WO2004017997A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | WO2004017989A1 Methods for improving islet signaling in diabetes mellitus and for its prevention |
| 03/04/2004 | WO2004017986A1 Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia |
| 03/04/2004 | WO2004017969A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 03/04/2004 | WO2004017957A1 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 03/04/2004 | WO2004017956A1 Dosage forms and related therapies |
| 03/04/2004 | WO2004017906A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 03/04/2004 | WO2004017766A1 Novel nutraceutical compositions comprising biotin |
| 03/04/2004 | WO2004009015A3 Combination therapy for the treatment of obesity |
| 03/04/2004 | WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003042214A3 A2b adenosine receptor antagonists |
| 03/04/2004 | WO2003032916A3 Organosulfur inhibitors of tyrosine phosphatases |
| 03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/04/2004 | WO2003016348A3 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 03/04/2004 | WO2003014114A3 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/04/2004 | WO2003002136A3 Stable formulation of modified glp-1 |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002094178A3 Treatment of renal fibrosis |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy |
| 03/04/2004 | WO2002066000A3 Novel cosmetic slimming compositions containing boldine |
| 03/04/2004 | WO2002059621A3 Regulation of transthyretin to treat obesity |
| 03/04/2004 | WO2002022134A8 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 03/04/2004 | US20040044272 Personal condition management system |
| 03/04/2004 | US20040044241 Novel succinate salt of O-desmethyl-venlafaxine |
| 03/04/2004 | US20040044227 From 1,3,8-octanetriol |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044067 Anticholesterol agents; dietetics; plant extract |
| 03/04/2004 | US20040044061 Analgesics; side effect reduction |
| 03/04/2004 | US20040044056 Benzimidazole derivatives |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |